论文部分内容阅读
目的了解经济状况对冠心病患者二级预防药物规范化使用的影响。方法对门诊冠心病患者进行问卷调查,根据个人收入、受教育程度等对社会经济地位进行划分,分析不同社会经济地位人群中冠心病患者药物使用率的差异,多因素Logistic回归模型分析经济地位对药物使用的影响。结果社会经济地位高组药物规范化使用率比社会经济地位低组高63.08%(OR=1.597,95%CI:1.032-2.907)。Logistic回归分析显示患者的收入低(OR=13.38)、自费(OR=9.56)是影响冠心病二级预防规范化药物使用的影响因素。结论社会经济地位低组药物规范化使用率低,收入低、没有医保是影响药物使用的影响因素。
Objective To understand the impact of economic status on the standardized use of secondary prevention in patients with coronary heart disease. Methods A questionnaire survey was conducted among outpatients with coronary heart disease and the socioeconomic status was divided according to personal income, educational level and so on. The differences of drug use rate among coronary heart disease patients in different socioeconomic status were analyzed. Multivariate logistic regression model was used to analyze the economic status The impact of drug use. Results The normalized socioeconomic status of drug use was 63.08% (OR = 1.597, 95% CI: 1.032-2.907) higher than the low socioeconomic status. Logistic regression analysis showed that patients had low income (OR = 13.38) and self-payment (OR = 9.56), which were the influencing factors for the standardized use of secondary prevention of coronary heart disease. Conclusion Low standardization of socioeconomic status of the use of low-standardized drugs, low income, no health insurance is the impact of drug use factors.